News

Adding narrowband ultraviolet B (UVB) phototherapy to oral treatment with ritlecitinib (Litfulo) enhanced repigmentation in patients with nonsegmental vitiligo compared with the drug alone ...
UVB narrowband: Many scientists and doctors think ... You'll probably need phototherapy treatments 3 days a week for 2 to 3 months. Your doctor might suggest you use UVB treatment along with ...
Phototherapy combined with topical antioxidants showed the highest efficacy for vitiligo repigmentation, outperforming other ...
Similar reductions were seen in body vitiligo severity. Narrow-band ultraviolet B phototherapy improved the efficacy of ritlecitinib for the treatment of patients with nonsegmental vitiligo ...
Joel M. Gelfand The answer: narrowband UVB phototherapy! Surprised? So was I, but these data are from the Vascular Inflammation in Psoriasis trial, a randomized placebo-controlled trial we ...
Treatment with “narrowband” UVB light -- which gives off a shorter wavelength than “broadband” UVB light -- is the most common type of phototherapy that doctors use for atopic dermatitis.
TUESDAY, April 8, 2025 (HealthDay News) -- Narrowband UVB (nbUVB) phototherapy may be underutilized in pediatric vitiligo, according to a study published online March 18 in Pediatric Dermatology.
In 2019, Gelfand and colleagues Light Treatment Effectiveness (LITE) study, a patient-centered study that tested the hypothesis that narrowband UVB phototherapy of psoriasis at home is non ...
Phototherapy, such as ultraviolet light ... 280-320 nm), combined ultraviolet-A and -B (UVAB, 280-400 nm), and Narrowband Ultraviolet-B (NB-UVB, 311-313 nm) therapy. Those who received whole ...
For decades, people with psoriasis have been treated in clinics with narrowband ultraviolet B phototherapy, or light therapy, to reduce sores, scales, and inflammation. Now, new research from the ...
Adding twice-weekly narrowband UVB phototherapy to oral ritlecitinib may enhance response to treatment of nonsegmental vitiligo. Dual treatment was well-tolerated with no new safety signals in ...